Background
Results
KIFC1 is overexpressed in Epithelial Ovarian adenocarcinoma (EOC) clinical samples
Variable | Level | Number | Percentage |
---|---|---|---|
Age | 20–40 | 23 | 19.2 |
41–60 | 81 | 67.5 | |
61< | 16 | 13.3 | |
Grade | 1 | 32 | 26.7 |
2 | 36 | 30 | |
3 | 46 | 38.3 | |
Unknown | 6 | 5 | |
Stage | I | 69 | 57.5 |
II | 31 | 25.8 | |
III | 12 | 10 | |
IV | 3 | 2.5 | |
Unknown | 5 | 4.2 | |
Primary Tumor (T) | T1 | 72 | 60 |
T2 | 31 | 25.8 | |
T3 | 12 | 10 | |
Unknown | 5 | 4.2 | |
Regional Lymph Nodes (N) | N0 | 103 | 85.8 |
N1 | 12 | 10 | |
Unknown | 5 | 4.2 | |
Distant metastasis | Yes | 3 | 2.5 |
No | 112 | 93.3 | |
Unknown | 5 | 4.2 | |
Tissue type | Malignant | 115 | 95.8 |
Metastasis | 5 | 4.2 |
Variable | Level | Number | Percentage |
---|---|---|---|
Pathological diagnosis | Adenocarcinoma | 2 | 1.7 |
Serous Adenocarcinoma | 6 | 5 | |
Serous Papillary Adenocarcinoma | 3 | 2.5 | |
Endometrioid Adenocarcinoma | 10 | 8.3 | |
Metastatic Adenocarcinoma | 4 | 3.3 | |
Metastatic Mucinous Adenocarcinoma | 1 | 0.8 | |
Mucinous Adenocarcinoma | 11 | 9.2 | |
Clear Cell Carcinoma | 4 | 3.3 | |
Serous Papillary Carcinoma | 32 | 26.7 | |
Serous Papillary Cystadenocarcinoma | 47 | 39.2 |
Variable | Level | Number | Percentage |
---|---|---|---|
Age (Range) | 20–29 | 1 | 0.5 |
30–39 | 4 | 1.9 | |
40–49 | 23 | 11.1 | |
50–59 | 84 | 40.4 | |
60–69 | 54 | 26 | |
70–79 | 40 | 19.2 | |
80–89 | 1 | 0.5 | |
Unknown | 1 | 0.5 | |
Cancer site | Primary | 154 | 74 |
Metastasis | 50 | 24 | |
Unknown | 4 | 1.9 | |
FIGO Stage | I | 9 | 4.3 |
II | 9 | 4.3 | |
III | 126 | 60.6 | |
IV | 10 | 4.8 | |
Unknown | 54 | 26 | |
Grade | 1 | 6 | 2.9 |
2 | 80 | 38.5 | |
3 | 120 | 57.7 | |
Unknown | 2 | 1 | |
Survival Status | Alive | 109 | 52.4 |
Dead | 98 | 47.1 | |
Unknown | 1 | 0.5 | |
Recurrence | Recurrence | 154 | 74 |
No Recurrence | 53 | 25.5 | |
Unknown | 1 | 0.5 |
Enhanced KIFC1 gene expression is associated with poor survival in HGSOC patients
KIFC1 gene expression correlates with expression of genes related to centrosomal amplification in serous ovarian cancer
Gene | Pearson correlation |
P-Value |
---|---|---|
CCNA2 | 0.62527 | <.0001 |
NEK2 | 0.60066 | <.0001 |
E2F1 | 0.54218 | <.0001 |
CDK1 | 0.52124 | <.0001 |
E2F2 | 0.51764 | <.0001 |
AURKA | 0.46987 | <.0001 |
STIL | 0.397 | <.0001 |
CCNE2 | 0.36387 | <.0001 |
LMO4 | 0.36306 | <.0001 |
PLK4 | 0.34292 | <.0001 |
MYCN | 0.31914 | <.0001 |
E2F3 | 0.31548 | <.0001 |
MDM2 | 0.24766 | 0.002 |
PIN1 | 0.23016 | 0.0041 |
CEP152 | 0.18128 | 0.0245 |
PIM1 | 0.17826 | 0.027 |